| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-09 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-07 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.33 | 4e-06 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |